EFG Asset Management North America Corp. Boosts Stock Position in Intuitive Surgical, Inc. $ISRG

EFG Asset Management North America Corp. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,653 shares of the medical equipment provider’s stock after purchasing an additional 1,206 shares during the period. Intuitive Surgical comprises approximately 0.8% of EFG Asset Management North America Corp.’s holdings, making the stock its 24th largest holding. EFG Asset Management North America Corp.’s holdings in Intuitive Surgical were worth $6,553,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in ISRG. Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after buying an additional 670,302 shares in the last quarter. State Street Corp grew its stake in Intuitive Surgical by 1.2% in the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after acquiring an additional 182,871 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Intuitive Surgical by 1.4% during the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock worth $4,429,590,000 after acquiring an additional 109,904 shares during the period. Norges Bank purchased a new position in shares of Intuitive Surgical during the second quarter worth approximately $2,569,260,000. Finally, Invesco Ltd. raised its stake in shares of Intuitive Surgical by 4.8% during the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock valued at $2,402,488,000 after acquiring an additional 201,159 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, Director Craig H. Barratt sold 750 shares of Intuitive Surgical stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $435,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the transaction, the executive vice president directly owned 3,056 shares in the company, valued at approximately $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 48,152 shares of company stock valued at $27,470,571 over the last quarter. Insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, January 21st. Jefferies Financial Group increased their price target on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. UBS Group restated a “neutral” rating on shares of Intuitive Surgical in a report on Thursday, January 15th. Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday. Finally, The Goldman Sachs Group reissued a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research report on Friday, January 9th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $618.52.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $528.81 on Tuesday. The stock’s 50-day moving average is $561.96 and its 200 day moving average is $511.58. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $609.08. The company has a market cap of $189.57 billion, a P/E ratio of 67.02, a PEG ratio of 4.26 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. During the same period in the prior year, the firm posted $2.21 earnings per share. The company’s quarterly revenue was up 18.8% on a year-over-year basis. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.